A new study in JAMA Internal medicine has found that the concurrent use of interacting medications has increased since 2005 and that 15% of older adults are potentially at risk for a major drug-drug interaction.
Prescription medications, over-the-counter (OTC) medications, dietary supplements…the list of the number of medications that an individual is exposed to can be ever-expanding—especially so if the person suffers from comorbidities, which is a common occurrence in geriatric patients. Now a new study has found that the concurrent use of interacting medications has increased since 2005 and that 15% of older adults are potentially at risk for a major drug-drug interaction.
Researchers at the University of Illinois at Chicago and at Johns Hopkins collaborated on this study to conduct in-house interviews and direct medication inspection of adults in the age group of 62 to 85 years. The interviews were first conducted in 2005-2006 and again in 2010-2011, to compare and contrast prevalence of medication use and the concurrent use of prescription and OTC medications and dietary supplements. Additionally, the prevalence of drug-drug interactions was also monitored.
The increase in polypharmacy (use of multiple medications) “Is a concern from a public health standpoint, because it’s getting worse,” said Dima Qato, PharmD, MPH, PhD, from the University of Illinois at Chicago and lead author on the study, in an interview with Reuter’s.
More than 2000 adults were interviewed during both times periods, with a mean age of 70.9 years in 2005-2006 and 71.4 years in 2010-2011. From 2005-2006 to 2010-2011, the study observed the following:
Additional analysis based on these trends in use of medications and supplementary products found that in the 2010-2011 time period, a little over 15% of the geriatric population was at greater risk of a major drug-drug interaction, nearly double the 8.4% in 2005-2006 (P < .001).
Further, a majority of these interactions involved those medications and dietary supplements that saw an increased use in 2010-2011.
“I think we have to keep in mind that while it’s important to improve access to medications, we need to make sure they’re used safely,” said Qato.
In an invited commentary in the same issue of JAMA Internal Medicine in which this article was published, Michael A. Steinman, MD, a geriatrician, writes, “The number of medications a person uses is by far the strongest risk factor for medication-related problems. As the number of medications rises, adverse drug reactions become more common. Adherence worsens. Out-of-pocket costs rise. Drug-drug interactions increase. The use of potentially inappropriate and unnecessary medications escalates.”
Reference
Qato DM, Wilder J, Schumm LP, Gillet V, Alexander GC. Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011 [published online March 21, 2016]. JAMA Intern Med. doi:10.1001/jamainternmed.2015.8581.
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More